Related Experiment Video
Updated: Jul 5, 2025

11:18
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.1K
Matching Patients to Accelerate Clinical Trials (MPACT): Enabling Technology for Oncology Clinical Trial Workflow.
Nhan V Do1,2, Danne C Elbers1,3, Nathanael R Fillmore1,3
1VA Boston Healthcare System, Boston MA, USA.
Studies in Health Technology and Informatics
|January 25, 2024
Summary
The MPACT platform streamlines clinical trial screening for cancer patients within the Veterans Health Administration (VHA). This tool uses Natural Language Processing to reduce the time research coordinators spend identifying eligible participants.
Area of Science:
- Oncology
- Health Informatics
- Clinical Trial Management
Background:
- Clinical trial enrollment faces significant delays due to the time-intensive patient screening process.
- The Veterans Health Administration (VHA) prioritizes enhancing Veteran access to high-quality cancer clinical trials.
Purpose of the Study:
- To develop and evaluate the MPACT (Matching Patients to Accelerate Clinical Trials) platform.
- To improve the efficiency of the clinical trial screening process for research coordinators.
Main Methods:
- Developed the MPACT platform with input from research coordinators.
- Integrated Natural Language Processing (NLP) and Data Science for eligibility criteria phenotyping.
- Implemented workflows for trial prescreening and patient screening.
- Included functionality for tracking patient eligibility status over time.
Main Results:
- MPACT employs NLP and Data Science to generate reliable phenotypes of trial eligibility criteria.
- The platform supports both prescreening and screening workflows.
- Users reported a reduction in the time required to identify eligible patients.
- Qualitative feedback indicates promising improvements in screening efficiency.
Conclusions:
- The MPACT platform effectively addresses the time burden in clinical trial screening.
- MPACT enhances efficiency in identifying eligible patients for cancer clinical trials within the VHA.
- The use of NLP and Data Science in MPACT shows potential for broader application in clinical trial matching.
Related Concept Videos
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K

